<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine
Image Overlay - Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Patients enrolled in the Pfizer and BioNTech clinical trial for a COVID-19 vaccine who originally receive a placebo will now be given the preventative vaccine. This will not occur until the U.S. Food and Drug Administration grants the vaccine an emergency use authorization or further regulatory approval, however. Trials are generally blinded so participants do not know whether they are receiving a placebo or treatment – though Pfizer hopes to amend this pending approval from regulatory bodies. Yourway has worked throughout the coronavirus pandemic to ensure drug products are delivered on time and even directly to patients, 24/7.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?